Only a day after scientists noted a breakthrough that might eliminate the need to use embryonic stem cells to pursue their research and thereby avoid the thorny ethical and moral dilemmas, the House approved a revised stem cell bill that pushes embryonic stem cell funding.
That approval was by a vote of 247-176. The New York Times characterizes this as overwhelming support. Sorry, but it is far from overwhelming. It doesn't even have sufficient votes to override the President's veto, which is just as surely to be issued as it was the last time Congress sent him a stem cell bill not to his liking.
This bill falls 33 votes short of having sufficient votes to be able to override the veto in the House and at least one vote short in the Senate.
In other words, it is not overwhelming. It doesn't have the kind of support the NYT wishes it did.
No comments:
Post a Comment